Breast cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patients with breast masses on examinations such as ultrasound, mammography, or MRI of any kind, especially BI-RADS category 3 and 4 patients; (2) Informed of this study and signed an informed consent form. Voluntary shear wave elastography examination; (3) Agreed and combined with puncture biopsy, rotary biopsy, or surgical treatment, and finally obtained the pathological diagnosis.
Exclusion criteria
Exclusion criteria: (1) Pregnancy or lactation; (2) Implants in the breast; (3) History of surgery on the affected side; (4) History of malignant tumor and other cachexia.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Radiomic features;assess the breast cancer risk via deep-learning based AI system;Mammogram breast density types;BI-RADS classification (mammogram);Biopsy Method;Histological type;WHO histological grading;Vessel carcinoma embolus;Nerve Violation;ER;PR;HER2;FISH;KI-67;Molecular subtypes (biopsy);Lymph node biopsy results;cTNM staging;Neoadjuvant treatment programs;Surgery Date;Surgical method;Histological type (surgery);Number of positive SLN by intraoperative cryopreservation;Number of positive SLN by postoperative paraffin examination;Number of NSLN positives;pTNM staging;Molecular subtypes (surgery);Concordance of biopsy and postoperative molecular subtypes;Miller-Payne Classification;RCB Classification;Whether or not pCR;Adjunctive therapy programs;Prognosis Information;Pathogenomic features;Mass size;Echo;Boundary of the mass;Mass pattern;Calcification;BI-RADS Classification;PSV;EDV;RI;S/D;Emax;Emin;Emean;SD;Eratio;Area;Berg' color scoring;Tozaki M four-color model; | — |
Secondary
| Measure | Time frame |
|---|---|
| age;Menstrual status;Personal Cancer History;Family history of cancer;Location;Distance to nipple; | — |
Countries
China
Contacts
The First Affiliated Hospital of Anhui Medical University